Related Experiment Video

Updated: Sep 8, 2025

A High-throughput Assay to Assess and Quantify Neutrophil Extracellular Trap Formation
09:59

A High-throughput Assay to Assess and Quantify Neutrophil Extracellular Trap Formation

Published on: January 29, 2019

10.1K

A Novel Antineutrophil Extracellular Trap Antibody Targeting Myosin Light Chain 6 in Microscopic Polyangiitis

Miku Yoshinari1, Fumihiko Hattanda2, Yuka Nishibata1

  • 1Department of Medical Laboratory Science, Faculty of Health Sciences, Hokkaido University.

The Journal of Rheumatology
|June 15, 2022
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Real-Time, High-Throughput Microscopic Quantification of Human Neutrophil Extracellular Trap Release and Assessing the Pharmacology of Antagonists
11:32

Real-Time, High-Throughput Microscopic Quantification of Human Neutrophil Extracellular Trap Release and Assessing the Pharmacology of Antagonists

Published on: October 18, 2024

712
Author Spotlight: Neutrophil Extracellular Traps Imaging in Human and Mouse Tissues
07:36

Author Spotlight: Neutrophil Extracellular Traps Imaging in Human and Mouse Tissues

Published on: August 18, 2023

7.4K

Related Experiment Videos

Last Updated: Sep 8, 2025

A High-throughput Assay to Assess and Quantify Neutrophil Extracellular Trap Formation
09:59

A High-throughput Assay to Assess and Quantify Neutrophil Extracellular Trap Formation

Published on: January 29, 2019

10.1K
Real-Time, High-Throughput Microscopic Quantification of Human Neutrophil Extracellular Trap Release and Assessing the Pharmacology of Antagonists
11:32

Real-Time, High-Throughput Microscopic Quantification of Human Neutrophil Extracellular Trap Release and Assessing the Pharmacology of Antagonists

Published on: October 18, 2024

712
Author Spotlight: Neutrophil Extracellular Traps Imaging in Human and Mouse Tissues
07:36

Author Spotlight: Neutrophil Extracellular Traps Imaging in Human and Mouse Tissues

Published on: August 18, 2023

7.4K

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

1.9K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.9K

Articles linked to this work by shared authors, journal, and citation graph.

Neutrophil extracellular traps induced by a monoclonal anti-phosphatidylserine/prothrombin antibody activate platelets in vitro.

Experimental and molecular pathology·2026

Multifocal Glucocorticoid-Associated Osteonecrosis: Clinical Characteristics and Systemic Molecular Features.

Biomedicines·2026

Vessel wall enhancement in brain arteriovenous malformations: associations with imaging and histopathological markers of instability.

Neurosurgical review·2026

Hyperlipidemia promotes neutrophil extracellular trap-mediated osteonecrosis of the femoral head following methylprednisolone pulse in lupus mice.

Immunobiology·2026

Successful treatment with clofazimine for macrolide-resistant Mycobacterium abscessus infection in a peritoneal dialysis patient: A case report and literature review.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2026

Establishment of a mouse model of propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis.

Animal models and experimental medicine·2026

Rethinking Anti-CD20 Therapies: From Fixed to Precision Dosing.

The Journal of rheumatology·2026

Longitudinal comparison of treat-to-target states and clinical outcomes in patients with late-onset versus early-onset systemic lupus erythematosus.

The Journal of rheumatology·2026

Remission rates of patients with axial spondyloarthritis in a tertiary care center.

The Journal of rheumatology·2026

Uncovering heterogeneous health burden in axial spondyloarthritis through latent class analysis of the ASAS health index.

The Journal of rheumatology·2026

Mendelian randomisation for rheumatology: beyond hype-what it's good for, what it can't do, and how to read it critically.

The Journal of rheumatology·2026

Juvenile Arthritis Quality of Life Questionnaire Responder Metrics in Juvenile Idiopathic Arthritis: Clarifying Health-Related Quality of Life Changes Across Treatment Eras.

The Journal of rheumatology·2026

Small Bowel Lymphangiomatosis Presenting With Amyloidosis: A Case Report.

Cureus·2026

Intestinal Lymphangioma With Extensive Secondary Lymphangiectasia Causing Life-Threatening Hemorrhage: First Case Requiring Small Bowel Transplantation.

Case reports in pathology·2026

Atypical Nodular Hidradenoma of the Postauricular Region: A Report of a Rare Case With Radiological, Histopathological, and Immunohistochemical Correlation.

Cureus·2026

Treatment patterns, access, and multidimensional burden of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) in China: A nationwide cross-sectional study.

Therapeutic advances in neurological disorders·2026

Efficacy and safety of interleukin-6 receptor inhibitors in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): A systematic review and meta-analysis.

Therapeutic advances in neurological disorders·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us